Global Precision Medicine Market, By Technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular, Diagnostics, Big Data Analytics), Application (Oncology, CNS, Hematology, Respiratory, Immunology), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025
- Report code : CMI6145 |
- Industry :
Pharmaceutical
- Published On : Sep 2017 |
- Pages : 178 Pages |
- Format :
Precision Medicine Market – Not one-size fits all
Precision medicine is an emerging field, which tailors the treatment according to the individual’s genetic makeup, lifestyle, and environment. The precision medicine have gained popularity due to the positive result obtained by precision medicine in treatment of cancer. It allows the doctors and researchers to predict more accurate treatment and preventive strategies for any particular disease. Precision medicine has also challenged the approach of one drug fits all, as every person has unique genetic structure, which makes it impossible for one drug to work on whole population. Precision medicine is also known personalized medicine or individualized medicine, which target the mutations of normal body cells into cancerous cells. The use of precision medicine in targeted treatment specifically with cancer cells tends to experience less side effects with quick recovery as compared to conventional drugs.
Furthermore, improvement in FDA oversights of the drugs tests and other technologies support the innovation in precision medicine by ensuring that they are safe and effective. The advancement in genetic sequencing also supports the precision medicine, as it is completely dependent on the genetic sequencing.
The global precision medicine market was valued at US$ 45,720.8 million in 2016 and is expected to witness a robust CAGR of 9.9% during the forecast period (2017-2025).
Global Precision Medicine Market by Region- 2016 (US$ Mn)
Source: Coherent Market Insights (2017)
Government initiative for precision medicine is expected to fuel the growth of the precision medicine market in the near future.
North America accounts for the largest share in the global precision medicine market, followed by Europe. This is mainly attributed to awareness and initiative related to precision medicine in the North America. In 2015 President Obama announced the launch of Precision Medicine Initiative, that aimed to revolutionize the way of treatment to improve the health, as precision medicine provide an innovative approach that studies the unique gene sequences of individual and offer the tailored treatment. Precision Medicine Initiative have led to powerful novel discoveries and several advanced treatments, which are tailored for specific characteristic such as, genetic makeup or genetic profile of an individual tumor that helps to transform the way of treatment and favors the growth of precision medicine market in near future. The precision medicine initiative invested US$215 million in the National Institutes of Health in fiscal 2016 budget, which is expected to accelerate biomedical research by providing advanced tools and innovative therapies to the physicians, which are tailored according to individual need, in turn fueling the growth of precision medicine market in near future.
Development of big data analysis and IT sector are expected to drive growth of the precision medicine market
The cost and time required for developing new precision medicines is expected to reduce due to the development of big data analysis and IT sector. Moreover, the development of new precision medicines will help in providing the right prescription to improve patient’s health. Huge amount of useful data required for tailored prescription is created by numerous genetic tests and diagnostic tests, which are to be carried out to provide precision medicines. Physicians are able to provide precision medicine, as big data analysis and IT are able to crunch, analyze, and store the necessary data. Key players in the market who are working towards developing bioinformatics technology for precision medicine research applications are funded by the government. For instance, in August 2017, Armonica Technologies, Inc., an Albuquerque-based company, received US$ 1.5 million as a catalyst fund.
The drugs developed by manufacturers are hard to approve and expensive. They are not functional for large number of population, which has built the pressure on pharmaceutical companies to develop an active drug to cure the disease, which can be done with the help of Big Data Analysis and IT sectors to manufacture the precision medicines.
Some major players operating in the precision medicine market includes Intomics, ferrer incode, Nanostring Technologies, Inc.Tepnel Pharma Services, Pfizer, Inc., Novartis AG, Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics.
Growth restraining factors for precision medicine include unavailability of the insurance coverage on the genetic test, which is a mandatory test to analysis the mutation and according to it precision medicine could be provided. High cost of genetic test also hampers the growth of precision medicine market.
Precision medicine initiative aims to use advances in clinical and basic research to develop therapeutics that selectively target and kill cancer cells. This allows researchers to develop chemically tractable probes that can image cancer in Vivo. Precision medicine is used to treat children or adolescent patients suffering from brain tumor that have no other effective therapies. Various companies are continuously investing in research and development to further refine precision medicines for interventional surgical imaging, as well as for diagnostic and therapeutic applications. In 2015, Pfizer, Inc. established Center of Excellence in Precision Medicine (CEPM) in Chile, in partnership with Thermo Fisher Scientific, to validate new, more precise, and less invasive technologies for diagnosing cancer.
Furthermore, precision medicine is proving to be effective in treating oncology-related diseases, cardiovascular diseases, psychiatric disorders, neurodegenerative diseases, arthritis, obesity, diabetes, pain, and Alzheimer’s disease. Reduced cost of treatment attracts patient toward the precision medicine, as precision medicine cuts down most of the expensive treatments, which are not required since genetic testing helps the oncologists offer precision medicine.
Market Dynamics
The two recent FDA drug approvals, Kalydeco (ivacaftor) and Keytruda (pembrolizumab), pertaining to 33 cystic fibrosis mutations and cancer treatment based on a genetic feature respectively, point to an encouraging future for precision medicine. National Cancer Institute (NCI) conducts NCI-COG Pediatric MATCH trial that enrolls children and adolescents by advanced cancer therapy based on their genetic abnormality, where NCI also plans to support new immunotherapy clinical trials, antibody, testing of new combinations of the cell, small molecule, and radiation therapy studies, which include sequencing of tumor specimens. In July 2017, NCI has also launched various precision medicine trials, which include Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST), Lung Cancer Master Protocol (Lung-MAP), Molecular Analysis for Therapy Choice (NCI-MATCH), and Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT).
To reach full potential of precision medicine, collaboration among multiple players is required.
Market Taxonomy
This report segments the global precision medicine market on the basis of technology and application. On the basis of technology, the global precision medicine market is segmented into bioinformatics, gene sequencing, drug discovery, precision molecular diagnostics, and big data analytics. Applications of precision medicine include oncology, CNS, hematology, respiratory, and immunology, among others.
Key features of the study:
- This report provides an in-depth analysis of precision medicine in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2016 – 2024), considering 2015 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, product pipeline, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global precision medicine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include Novartis AG, Intomics, Ferrer Incode, Nanostring Technologies, Inc., Pfizer, Inc., Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
- The global precision medicine market report caters to various stakeholders in this industry including investors, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the precision medicine market
Detailed Segmentation:
- Global Precision Medicine Market, By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- Global Precision Medicine Market, By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Global Precision Medicine Market, By Geography:
- North America
- U.S.
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Canada
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Europe
- U.K.
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Germany
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Italy
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- France
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Russia
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Rest of Europe
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Asia Pacific
- China
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- India
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Japan
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- ASEAN
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Australia
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- South Korea
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Rest of Asia Pacific
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Latin America
- Brazil
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Mexico
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Rest of Latin America
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Middle East
- GCC
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Israel
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Africa
- North Africa
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Central Africa
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- South Africa
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Company Profiles
- Intomics.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Ferrer Incode
- Nanostring Technologies, Inc.
- Tepnel Pharma Services
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals
- Merck & Co., Inc.
- Qiagen N.V.
- Quest Diagnostics
“*” marked represents similar segmentation in other categories in the respective section.
- Canada
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Europe
- U.K.
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Germany
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Italy
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- France
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Russia
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Rest of Europe
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Asia Pacific
- China
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- India
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Japan
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- ASEAN
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Australia
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- South Korea
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Rest of Asia Pacific
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Latin America
- Brazil
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Mexico
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Rest of Latin America
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Middle East
- GCC
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Israel
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Africa
- North Africa
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Central Africa
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- South Africa
- By Technology:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- Breast cancers
- Lung Cancer
- Others
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Company Profiles
- Intomics.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Ferrer Incode
- Nanostring Technologies, Inc.
- Tepnel Pharma Services
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals
- Merck & Co., Inc.
- Qiagen N.V.
- Quest Diagnostics
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Technology
- Market Snippet By Application
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- Market Trends
- Value Chain
- Global Precision Medicine Market, By Technology, 2017 and 2025 (USD Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 and 2025
- Segment Trends
- Bioinformatics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Gene Sequencing
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Precision Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Big Data Analytics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Global Precision Medicine Market, By Application, 2017 and 2025 (USD Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 and 2025
- Segment Trends
- Oncology
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 and 2025
- Breast Cancer
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 and 2025
- Lung Cancer
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 and 2025
- Others
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 and 2025
- CNS
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Hematology
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Immunology
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
- Global Precision Medicine Market, By Regions, 2017 and 2025 (USD Million)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, For Regions, 2017 and 2025
- North America
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 and 2025
- U.S.
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Canada
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Europe
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 and 2025
- U.K.
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Germany
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Italy
- Market Size and Forecast, 2017 and 2025 (USD Million)
- France
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Russia
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Others
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Asia Pacific
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 and 2025
- China
- Market Size and Forecast, 2017 and 2025 (USD Million)
- India
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Japan
- Market Size and Forecast, 2017 and 2025 (USD Million)
- ASEAN
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Australia
- Market Size and Forecast, 2017 and 2025 (USD Million)
- South Korea
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Others
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Latin America
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 and 2025
- Brazil
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Mexico
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Others
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Africa
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 and 2025
- Northern Africa
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Central Africa
- Market Size and Forecast, 2017 and 2025 (USD Million)
- South Africa
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Middle East
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 and 2025
- GCC Countries
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Israel
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Rest of Middle East
- Market Size and Forecast, 2017 and 2025 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Intomics
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Ferrer Incode
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Nanostring Technologies, Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Tepnel Pharma Services
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Pfizer, Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Novartis AG
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Teva Pharmaceuticals
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Merck & Co., Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Qiagen N.V.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Quest Diagnostics
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 23 market data tables and 29 figures on "Precision Medicine Market - Global forecast to 2025”.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
- Primary Research (Trade Surveys and Experts Interviews)
- Desk Research
- Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
- National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
- Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
- Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
- Trade association, National and international media and trade press.
- Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
- Scientific journals, and other technical magazines and whitepapers.
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Data Standardization:
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
- Micro-economic indicators
- Macro-economic indicators
- Environmental indicators
- Socio-political indicators
- Technology indicators
Data Processing
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
Data Validation
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
- It provides first-hand information on the market dynamics, outlook, and growth parameters.
- Industry experts validates the estimates which helps the company to cement the on-going research study.
- Primary research includes online surveys, face-to face interviews, and telephonic interviews.
The primary research is conducted with the ecosystem players including, but not limited to:
- Raw Material Suppliers
- Manufacturers
- System Integrators
- Distributors
- End-users
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.